Key Insights
The Brazilian contraceptive devices market, valued at approximately $XX million in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 6.70% from 2025 to 2033. This expansion is fueled by several key drivers. Increasing awareness of family planning and reproductive health, coupled with government initiatives promoting access to contraception, significantly contributes to market growth. Furthermore, rising urbanization and changing socio-economic factors are influencing the adoption of modern contraceptive methods. The market is segmented by type (condoms, diaphragms, IUDs, etc.) and gender, with condoms and IUDs likely holding significant market shares due to their widespread use and accessibility. While the market faces some restraints, including cultural and religious beliefs that may limit contraceptive adoption in certain segments of the population, the overall positive trajectory is driven by a growing demand for effective and accessible birth control options.
However, challenges remain. Uneven distribution networks and limited access to healthcare in certain regions may hinder market penetration. The success of market players will depend on effective marketing strategies that target specific demographics and address regional disparities in access. A strong emphasis on education and awareness campaigns about reproductive health could further stimulate market growth. Key players such as AbbVie Inc (Allergan PLC), Ansell Ltd, and Bayer AG are likely actively competing to capture significant market share by innovating in product offerings and expanding their distribution networks within Brazil. The continued focus on improving access to a diverse range of contraceptive devices will be crucial for sustained market expansion throughout the forecast period.

Brazil Contraceptive Devices Industry: Market Report 2019-2033
This comprehensive report provides an in-depth analysis of the Brazil contraceptive devices industry, covering market size, growth drivers, competitive landscape, and future outlook from 2019 to 2033. The study period spans 2019-2024 (historical period), with 2025 as the base and estimated year, and a forecast period extending to 2033. The report is crucial for industry stakeholders, investors, and researchers seeking actionable insights into this dynamic market.
Brazil Contraceptive Devices Industry Market Structure & Competitive Dynamics
This section analyzes the competitive intensity, innovation, regulations, and market dynamics within the Brazilian contraceptive devices sector. The market is moderately concentrated, with key players holding significant shares. Market share data for 2024 reveals that the top five companies (AbbVie Inc (Allergan PLC), Ansell Ltd, Bayer AG, Reckitt Benckiser Group plc, and Johnson & Johnson) collectively control approximately xx% of the market. The remaining share is distributed among numerous smaller players and local manufacturers.
The Brazilian regulatory landscape, overseen by Anvisa (Agência Nacional de Vigilância Sanitária), plays a crucial role in shaping the market. Stringent regulations regarding product safety and efficacy influence innovation and entry barriers. The presence of substitute products, such as natural family planning methods, also impacts market growth. Significant M&A activity has been observed in recent years, with deal values exceeding USD xx Million in the period 2019-2024, primarily driven by consolidation efforts and expansion strategies of multinational corporations. End-user trends reveal a growing preference for more convenient and discreet contraceptive methods. Further analysis of consumer behavior and its impact on the market segment is incorporated within the detailed report.
- Market Concentration: Moderately concentrated, with top 5 players controlling xx% of the market in 2024.
- Innovation Ecosystem: Moderate level of innovation, influenced by regulatory frameworks.
- Regulatory Frameworks: Stringent regulations enforced by Anvisa.
- Product Substitutes: Natural family planning methods pose a competitive challenge.
- End-User Trends: Increasing demand for convenient and discreet options.
- M&A Activity: Significant deals, exceeding USD xx Million (2019-2024).
Brazil Contraceptive Devices Industry Trends & Insights
The Brazilian contraceptive devices market exhibits a steady growth trajectory, driven by increasing awareness of family planning, rising urbanization, and government initiatives promoting reproductive health. The market is segmented by type (condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, other devices) and gender (male, female). The CAGR (Compound Annual Growth Rate) from 2019 to 2024 is estimated at xx%, with projections indicating a continued, albeit slightly moderated, growth rate of xx% during the forecast period (2025-2033). Market penetration is highest for condoms and IUDs, while other segments exhibit varying levels of penetration depending on factors like accessibility, awareness, and cost. Technological advancements such as improved materials, extended-use devices, and telehealth platforms influence market growth. Competitive dynamics are characterized by both price competition and the introduction of innovative products. Consumer preferences shift towards greater efficacy, convenience, and reduced side effects.

Dominant Markets & Segments in Brazil Contraceptive Devices Industry
The Brazilian contraceptive devices market is geographically diverse, with significant demand across various regions. However, urban centers in states like São Paulo, Rio de Janeiro, and Minas Gerais showcase the highest consumption due to increased awareness, better access to healthcare, and higher disposable income.
By Type:
- Condoms: Remains the dominant segment due to affordability and accessibility.
- IUDs: Experiences strong growth driven by government initiatives and efficacy.
- Other Devices: This category experiences moderate growth, driven by the rising preference for long-acting reversible contraceptives (LARCs).
By Gender:
- Female: The female segment represents a larger share of the market due to the broader range of available methods.
- Male: Condom usage remains the dominant contraceptive choice for men.
Key Drivers:
- Government initiatives promoting family planning.
- Increasing awareness of reproductive health.
- Growing urban population and increased access to healthcare.
- Expanding private healthcare sector and insurance coverage.
Brazil Contraceptive Devices Industry Product Innovations
Recent years have witnessed notable innovations in contraceptive devices, emphasizing user-friendliness, efficacy, and reduced side effects. The market is experiencing a shift towards long-acting reversible contraceptives (LARCs) like IUDs and implants, due to their extended effectiveness and reduced user intervention. Technological advancements in materials and formulations have led to more comfortable and efficient products. This has enhanced market competitiveness.
Report Segmentation & Scope
The report segments the Brazil contraceptive devices market by type and gender:
By Type: Condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and other devices. Each segment’s analysis includes growth projections, market size estimations (in Million USD), and competitive dynamics.
By Gender: Male and female. Analysis includes an assessment of specific contraceptive method usage and market share. The report provides detailed market size and forecast data for each segment, along with insights into market growth drivers, restraints, and opportunities.
Key Drivers of Brazil Contraceptive Devices Industry Growth
The Brazilian contraceptive devices market is fueled by several key drivers: Increased government support for family planning programs, improved healthcare infrastructure, rising awareness of reproductive health issues, and a growing preference for convenient and effective contraceptive options. Economic factors, such as increasing disposable incomes in urban areas, also contribute to market growth. Furthermore, the regulatory environment, while stringent, helps ensure product safety and fosters consumer confidence.
Challenges in the Brazil Contraceptive Devices Industry Sector
Challenges include limited access to contraceptives in remote areas, socio-cultural barriers hindering adoption of certain methods, and pricing pressures. Supply chain disruptions and the impact of fluctuating currency exchange rates pose further challenges to industry participants. The high cost of some advanced contraceptive methods can restrict accessibility for lower-income groups.
Leading Players in the Brazil Contraceptive Devices Industry Market
- AbbVie Inc (Allergan PLC)
- Ansell Ltd
- Veru Inc (The Female Health Company)
- Bayer AG
- Reckitt Benckiser Group plc
- Johnson & Johnson
- Merck & Co
- Church & Dwight Co Inc
- The Cooper Companies Inc
- Pfizer Inc
Key Developments in Brazil Contraceptive Devices Industry Sector
- August 2022: Anvisa approved a new contraceptive pill (Nextela by Libbs) anticipated to launch in 2023-2024, promising reduced health risks.
- June 2022: The Ministry of Health invested USD 95 Million in 31,600 IUD placement procedures to reduce unplanned pregnancies.
Strategic Brazil Contraceptive Devices Industry Market Outlook
The Brazilian contraceptive devices market is poised for continued growth, driven by factors such as increasing healthcare awareness, rising disposable incomes, and government initiatives. Strategic opportunities exist for companies focusing on innovative product development, improved distribution networks, and targeted marketing campaigns addressing diverse consumer needs. Expansion into underserved markets and collaborations with healthcare providers can further unlock growth potential. The market is expected to witness a gradual shift towards more effective and convenient contraceptive options, offering significant opportunities for companies catering to these evolving preferences.
Brazil Contraceptive Devices Industry Segmentation
-
1. Type
- 1.1. Condoms
- 1.2. Diaphragms
- 1.3. Cervical Caps
- 1.4. Sponges
- 1.5. Vaginal Rings
- 1.6. Intra Uterine Device (IUD)
- 1.7. Other Devices
-
2. Gender
- 2.1. Male
- 2.2. Female
Brazil Contraceptive Devices Industry Segmentation By Geography
- 1. Brazil

Brazil Contraceptive Devices Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 6.70% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies
- 3.3. Market Restrains
- 3.3.1. Side Effects Associated with the Use of Contraceptive Devices
- 3.4. Market Trends
- 3.4.1. Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Brazil Contraceptive Devices Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Condoms
- 5.1.2. Diaphragms
- 5.1.3. Cervical Caps
- 5.1.4. Sponges
- 5.1.5. Vaginal Rings
- 5.1.6. Intra Uterine Device (IUD)
- 5.1.7. Other Devices
- 5.2. Market Analysis, Insights and Forecast - by Gender
- 5.2.1. Male
- 5.2.2. Female
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Brazil
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. Competitive Analysis
- 6.1. Market Share Analysis 2024
- 6.2. Company Profiles
- 6.2.1 AbbVie Inc (Allergan PLC)
- 6.2.1.1. Overview
- 6.2.1.2. Products
- 6.2.1.3. SWOT Analysis
- 6.2.1.4. Recent Developments
- 6.2.1.5. Financials (Based on Availability)
- 6.2.2 Ansell Ltd
- 6.2.2.1. Overview
- 6.2.2.2. Products
- 6.2.2.3. SWOT Analysis
- 6.2.2.4. Recent Developments
- 6.2.2.5. Financials (Based on Availability)
- 6.2.3 Veru Inc (The Female Health Company)
- 6.2.3.1. Overview
- 6.2.3.2. Products
- 6.2.3.3. SWOT Analysis
- 6.2.3.4. Recent Developments
- 6.2.3.5. Financials (Based on Availability)
- 6.2.4 Bayer AG
- 6.2.4.1. Overview
- 6.2.4.2. Products
- 6.2.4.3. SWOT Analysis
- 6.2.4.4. Recent Developments
- 6.2.4.5. Financials (Based on Availability)
- 6.2.5 Reckitt Benckiser Group plc
- 6.2.5.1. Overview
- 6.2.5.2. Products
- 6.2.5.3. SWOT Analysis
- 6.2.5.4. Recent Developments
- 6.2.5.5. Financials (Based on Availability)
- 6.2.6 Johnson & Johnson
- 6.2.6.1. Overview
- 6.2.6.2. Products
- 6.2.6.3. SWOT Analysis
- 6.2.6.4. Recent Developments
- 6.2.6.5. Financials (Based on Availability)
- 6.2.7 Merck & Co *List Not Exhaustive
- 6.2.7.1. Overview
- 6.2.7.2. Products
- 6.2.7.3. SWOT Analysis
- 6.2.7.4. Recent Developments
- 6.2.7.5. Financials (Based on Availability)
- 6.2.8 Church & Dwight Co Inc
- 6.2.8.1. Overview
- 6.2.8.2. Products
- 6.2.8.3. SWOT Analysis
- 6.2.8.4. Recent Developments
- 6.2.8.5. Financials (Based on Availability)
- 6.2.9 The Cooper Companies Inc
- 6.2.9.1. Overview
- 6.2.9.2. Products
- 6.2.9.3. SWOT Analysis
- 6.2.9.4. Recent Developments
- 6.2.9.5. Financials (Based on Availability)
- 6.2.10 Pfizer Inc
- 6.2.10.1. Overview
- 6.2.10.2. Products
- 6.2.10.3. SWOT Analysis
- 6.2.10.4. Recent Developments
- 6.2.10.5. Financials (Based on Availability)
- 6.2.1 AbbVie Inc (Allergan PLC)
List of Figures
- Figure 1: Brazil Contraceptive Devices Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Brazil Contraceptive Devices Industry Share (%) by Company 2024
List of Tables
- Table 1: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 3: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 4: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Type 2019 & 2032
- Table 7: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Gender 2019 & 2032
- Table 8: Brazil Contraceptive Devices Industry Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Brazil Contraceptive Devices Industry?
The projected CAGR is approximately 6.70%.
2. Which companies are prominent players in the Brazil Contraceptive Devices Industry?
Key companies in the market include AbbVie Inc (Allergan PLC), Ansell Ltd, Veru Inc (The Female Health Company), Bayer AG, Reckitt Benckiser Group plc, Johnson & Johnson, Merck & Co *List Not Exhaustive, Church & Dwight Co Inc, The Cooper Companies Inc, Pfizer Inc.
3. What are the main segments of the Brazil Contraceptive Devices Industry?
The market segments include Type, Gender.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Incidence of Sexually Transmitted Diseases (STDs); Increase in Unplanned Pregnancies.
6. What are the notable trends driving market growth?
Condoms Segment is Expected to Witness a Significant Growth Over the Forecast Period.
7. Are there any restraints impacting market growth?
Side Effects Associated with the Use of Contraceptive Devices.
8. Can you provide examples of recent developments in the market?
August 2022: The National Health Surveillance Agency (Anvisa) approved a new contraceptive pill whose formulation is meant to be less harmful to women's bodies and lower the risk of thrombosis. According to the Libbs (Manufacturer), it is anticipated to arrive on store shelves in Brazil between 2023 and 2024 under the brand Nextela.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Brazil Contraceptive Devices Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Brazil Contraceptive Devices Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Brazil Contraceptive Devices Industry?
To stay informed about further developments, trends, and reports in the Brazil Contraceptive Devices Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence